ArticleBritish journal of cancer2024

EGLN3 attenuates gastric cancer cell malignant characteristics by inhibiting JMJD8/NF-κB signalling activation independent of hydroxylase activity.

Fenglin Cai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.